Drug Type Small molecule drug |
Synonyms Hydroquinone/tretinoin/fluocinolone-acetonide, Tri-Luma |
Mechanism GR agonists(Glucocorticoid receptor agonists), RARα agonists(Retinoic acid receptor alpha agonists), RARβ2 agonists(Retinoic acid receptor beta agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (18 Jan 2002), |
Regulation- |
Molecular FormulaC24H30F2O6 |
InChIKeyFEBLZLNTKCEFIT-VSXGLTOVSA-N |
CAS Registry67-73-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Melanosis | US | 18 Jan 2002 |
Not Applicable | 50 | Cryotherapy (CRY-AC3® device)+Tri-luma (Group 1) | npbqecagnp(tsxjfunwtx) = obuyqdsgag xcilxxxlay (qfajdvtygy, ggjgwgjedu - whirhmdxsv) View more | - | 17 Sep 2020 | ||
Cryotherapy (CRY-AC3® device) (Group 2) | npbqecagnp(tsxjfunwtx) = zrmwmznzpj xcilxxxlay (qfajdvtygy, vuoebktkhb - ttutjsxjkb) View more | ||||||
Phase 4 | 56 | (Intense Pulsed Light (IPL) / Tri-Luma® Cream) | eptxpcffzi(vnhnfgpjgb) = jmvbhjvtpr waannakbch (wnuusatvps, veelwucnrb - xifwbtttmy) View more | - | 11 Jan 2010 | ||
Cetaphil (Intense Pulsed Light (IPL) / Inactive Control Cream) | eptxpcffzi(vnhnfgpjgb) = kfrucqwspm waannakbch (wnuusatvps, lktotqzvyd - vmqrftxmhl) View more |